 Acute chronic hemodynamic effects xamoterol mild congestive heart failure Xamoterol new beta partial agonist potential cardiac response variations sympathetic tone patients heart failure properties beta-receptor stimulatory effects low levels sympathetic tone beta-receptor protective effects levels sympathetic tone acute effects intravenous i.v xamoterol hemodynamics rest exercise patients mild heart failure patients New York Heart Association class II class III due cardiomyopathic heart disease Cardiac index stroke volume stroke work index rest i.v administration xamoterol consistent net agonist effects exercise heart rate double product net antagonist effects preservation expected increases cardiac index systolic blood pressure hemodynamic findings ability xamoterol cardiac response variations sympathetic tone Tachyphylaxis arrhythmogenicity chronic use drugs full beta-agonist properties positive inotropes heart failure patients double-blind placebo-controlled crossover study chronic oral xamoterol therapy mg hemodynamic responses xamoterol end trial impairment exercise effects indicative response absence tachyphylaxis chronic therapy ambulatory electrocardiographic monitoring change ventricular arrhythmias oral treatment